Explore UAB

Gastroenterology & Hepatology

Forging the future of gastroenterology and hepatology

The UAB Division of Gastroenterology and Hepatology is an integral part of one of the nation's largest health systems. Nationally known for our compassionate care, cutting-edge research, and comprehensive training programs, we're dedicated to delivering the most advanced care.

OUR PROGRAMS

Preparing the next generation of physicians and scientists

We're dedicated to nurturing and guiding the future generation of physicians and physician-scientists, recognizing that our trainees are the cornerstone of our nation's healthcare system.

OUR PEOPLE

Home to leading experts and distinguished scholars

Our faculty, staff, and trainees play an exceptionally critical role in shaping the future of healthcare through their expertise in education, research, and clinical practice, driving innovation and excellence.

Latest Headlines

  • UAB Hospital continues to be the best hospital in Alabama, Birmingham metro, according to U.S. News & World Report
    Jul 16, 2024
  • UAB to offer free colonoscopy screenings to under- and uninsured for second consecutive year
    May 21, 2024
  • UAB HHT Clinic named Center of Excellence
    Jul 11, 2023
  • UAB surpasses 20,000 robotic surgeries milestone, looks to future of continued surgical care
    Apr 28, 2023


Research Assistant Professor of Microbiology
Phone: 205-934-4480
E-Mail: jannovak@uab.edu

novak

Dr. Novak studied biology at the Charles University in Prague, Czech Republic, where he received his B.S. and M.Sc. in the Department of Biology and Physiology.  He then earned his Ph.D. in cellular and molecular biology from the Institute of Microbiology of the Czech Academy of Sciences in Prague. After post-doctoral studies at the Institute of Microbiology and subsequently at UAB, he joined the Department of Oral Biology at UAB in 1994.  Since 1998, his primary appointment has been in the Department of Microbiology.

Dr. Novak’s work in mucosal immunology focuses on chronic inflammatory diseases, including IgA nephropathy, periodontal disease, inflammatory bowel disease and HIV-1 infection.  Related to these diseases, his laboratory studies the heterogeneity and regulation of glycosylation of IgG and IgA.  A major project addresses the pathological mechanisms involved in IgA nephropathy, such as IgA1 aberrant O-linked glycosylation and the resultant formation of IgA-1-containing immune complexes.  These studies have demonstrated that IgA nephropathy is an autoimmune disease. Currently, he is investigating the binding of pathogenic IgA1-containing immune complexes to human mesangial cells and the resultant cellular activation using differential gene and protein expression (DNA microarrays, RT-PCR, proteomics). Other projects include elucidating the biochemical interactions between bacteria or their products and mucosal epithelial cells, biochemical and structural features of bacterial hemolysins and quorum sensing molecules, and the biochemistry of mucosal bacteria and protozoa.

Selected Publications

  1. Novak, J., Kirk, M., Caufield P.W., Barnes, S., Morrison, K. and Baker, J.  Detection of modified amino acids in lantibiotic peptide mutacin II by chemical derivatization followed by electrospray ionization mass spectroscopic analysis. Anal. Biochem. 236:358-360, 1996.
  2. Tomana, M., Novak, J., Julian, B.A., Matousovic, K., Konecny, K. and Mestecky, J.  Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J. Clin. Invest. 104:73-81, 1999.
  3. Smith, L., Novak, J., Rocca, J., McClung, S., Hillman, J.D. and Edison, A.S. Covalent structure of mutacin 1140 and a novel method for the rapid identification of lantibiotics. Eur. J. Biochem. 267:6810-6816, 2000.
  4. Novak, J., Tomana, M., Kilian, M., Coward, L., Kulhavy, R., Barnes, S. and Mestecky, J.  Heterogenity of O-glycosylation in the hinge region of human IgA1. Mol. Immunol. 37:1047-1056, 2000.
  5. Stephenson, A.E., Wu, H., Novak, J., Tomana, M., Mintz, K. and Fives-Taylor, P.  The Fap1 fimbrial adhesin is a glycoprotein: Antibodies specific for the glycan moiety block the adhesion ofStreptococcus parasanguis in an in vitro tooth model. Mol. Microbiol. 43:147-158, 2002.
  6. Novak, J., Vu, H.L., Novak, L., Julian, B., Mestecky, J. and Tomana, M.  Interactions of human mesangial cells with IgA and IgA-containing circulating immune complexes. Kidney Int. 62:465-475, 2002.
  7. Julian, B.A. and Novak, J.  IgA nephropathy: an update.  Invited article. Curr. Opin. Nephrol. Hypertens. 13, 171-179, 2004.
  8. Novak, J., Tomana, M., Matousovic, K., Brown, R., Hall, S., Novak, L., Julian, B.A., Wyatt, R.J., and Mestecky, J.  IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int.  67, 504-513, 2005.
  9. Renfrow, M.B., Cooper, H. J., Tomana, M., Kulhavy, R., Hiki, Y., Toma, K., Emmett, M.R., Mestecky, J., Marshall A. G. and Novak, J.  Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation Fourier transform ion cyclotron resonance mass spectrometry. J. Biol. Chem. 2005. In Press.
  10. Moore, J.S., Wu, X., Kulhavy, R., Tomana, M., Novak, J., Moldoveanu, Z., Brown, R., Goepfert, P.A. and Mestecky, J.  Increased levels of galactose-deficient IgG in sera of HIV-1-infected individuals.AIDS  19, 381-389, 2005.